Ilsung re-strengthening strategic alliance with GSK Korea

Published: 2012-04-09 06:56:00

Updated: 2012-04-09 06:56:00

Ilsung Pharm is actively re-seeking strategic alliances with a Korean unit of GlaxoSmilthKline (GSK) over Augmentin, a penicillin antibiotic for treatment of various injections, using its strong sales and marketing force.

Ilsung and GSK Korea agreed Wednesday to jointly market Augmentin under...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK